Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide

General Pharmacology

Volumn 33, Issue 6, 1999, Pages 487-498

  Pruefer, Diethard ^a   Scalia, Rosario ^a   Lefer, Allan M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cell adhesion molecules: Leukocytes; Endothelial dysfunction; Homocysteine; Nitric oxide

Indexed keywords

HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; PADGEM PROTEIN;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; DOWN REGULATION; ENDOTHELIUM INJURY; HYPERHOMOCYSTEINEMIA; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK FACTOR;

ANIMALS; ANTIGENS, CD18; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HOMOCYSTEINE; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALE; MESENTERIC ARTERIES; NITRIC OXIDE; OXADIAZOLES; P-SELECTIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033371342     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(99)00045-2     Document Type: Article

References (47)

1. Arnaout M.A. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood. 75:1990;1037-1050.
2. Beckstead J.H., Stenberg P.E., McEver R.P., Shuman M.C., Bainton D.F. Immunohistological localization of membrane and α-granule proteins in human megakaryocytes. application to plastic embedded bone marrow biopsy specimens Blood. 67:1986;285-293.
3. Borders J.L., Granger H.J. An optical Doppler intravital velocimeter. Microvasc Res. 27:1984;117-127.
4. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. probable benefits of increasing folic acid intakes J Am Med Assoc. 274:1995;1049-1057.
5. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol. 5(suppl. 5):1976;9-15.
6. Butcher E.C. Leukocyte-endothelial cell recognition. three (or more) steps to specificity and diversity Cell. 67:1991;1033-1036.
7. Clancy R.N., Leszcyvka-Pirsok J., Abramson R.B. Nitric oxide, an endothelial cell relaxing factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest. 90:1992;1116-1121.
8. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocysteinemia. an independent risk factor for vascular disease N Engl J Med. 324:1991;1149-1155.
9. Davenpeck K.L., Gauthier T.W., Lefer A.M. Inhibition of endothelium derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology. 107:1994;1050-1058. a.
10. Davenpeck K.L., Gauthier T.W., Albertine K.H., Lefer A.M. Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am J Physiol. 267:1994;H622-H630. b.
11. Dudman N.P.B., Temple S.E., Guo X.W., Fu W., Perry M.A. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res. 84:1999;409-416.
12. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G. A candidate genetic risk factor for vascular disease. a common mutation in methylene tetrahydrofolate reductase Nat Genet. 7:1995;195-200.
13. Furchgott R.F., Zawadski J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle. Nature. 288:1980;373-376.
14. Gauthier T.W., Davenpeck K.L., Lefer A.M. Nitric oxide attenuates leukocyte-endothelial interaction via P-selection in splanchnic ischemia-reperfusion. Am J Physiol. 267:1994;G562-G568.
15. Granger D.N., Benoit J.N., Suzuki M., Grisham M.B. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol. 257:1989;G683-G688.
16. Guo J.P., Panday M.M., Consigny P.M., Lefer A.M. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol. 269:1995;H1122-H1131.
17. Guo J.P., Murohara T., Buerke M., Scalia R., Lefer A.M. Direct measurement of nitric oxide release from vascular endothelial cells. J Appl Physiol. 81:1996;774-779.
18. Kang S.S., Zhou J., Wong P.W.K., Kowalisyn J., Strokosch G. Intermediate homocysteinemia. a thermolabile variant of methylenetetrahydrofolate reductase Am J Hum Genet. 43:1988;414-421.
19. Kubes P., Suzuki M., Granger D.N. Nitric oxide. an endogenous modulator of leukocyte adhesion Proc Natl Acad Sci U S A. 88:1991;4651-4655.
20. Kurose I., Wolf R., Grisham M.B., Granger D.N. Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am J Physiol. 268:1995;H2224-H2231.
21. Kurtel H., Tso P., Granger D.N. Granulocyte accumulation in postischemic intestine. role of leukocyte adhesion glycoprotein CD11/CD18 Am J Physiol. 262:1992;G878-G882.
22. Lefer A.M., Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion. Cardiovasc Res. 32:1996;743-751.
23. Lefer A.M., Ma X.L. Endothelial dysfunction as an early critical event in ischemia and shock. Faist E., Meakins J.L., Schildberg F.W. Host defense dysfunction in trauma, shock and sepsis. 1993;107-112 Springer-Verlag, Heidelberg.
24. Lefer D.J., Nakanishi K., Johnston W.E., Vinten-Johanson J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation. 88:1993;2337-2350.
25. Lorant D.E., Patel K.D., McIntyre T.M., McEver R.P., Prescott S.M., Zimmerman G.A. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin. a juxtacrine system for adhesion and activation of neutrophils J Cell Biol. 115:1991;223-234.
26. Lorant D.E., Tophan M.K., Whatley R.E., McEver R.P., McIntyre T.M., Prescott S.M., Zimmermann G.A. Inflammatory roles of P-selectin. J Clin Invest. 92:1993;559-570.
27. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 98:1996;5-7.
28. McEver R.P., Beckstead J.H., Moore K.L., Marshall-Carlson L., Bainton D.F. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 89:1989;92-99.
29. Osborne J.A., Siegman M.J., Sedar A.W., Mooers S.U., Lefer A.M. Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol fed rabbits. Am J Physiol. 256:1989;C591-C597.
30. Patel K.D., Zimmermann G.A., Prescott S.M., McEver R.P., McIntyre T.M. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol. 112:1991;749-759.
31. Printseva O., Peclo M.M., Gown A.M. Various cell types in human atherosclerosis lesions express ICAM-1. further immunohistochemical and immunochemical studies employing monoclonal antibody 10F3 Am J Pathol. 141:1992;889-896.
32. Quere I., Hillary-Buys D., Brunschwig C., Chapal J., Janbon C., Blayac J.P., Petit P., Loubatieres-Mariani M.M. Effects of homocysteine on acetylcholine- and adenosine-induced vasodilation of pancreatic vascular bed in rats. Br J Pharmac. 122:1997;351-357.
33. Radomski M.W., Palmer R.M.J., Moncada S. Comparative pharmacology of the endothelium-derived relaxing factor nitric oxide and prostacyclin in platelets. Br J Pharmac. 92:1987;181-187.
34. Rubanyi G.M., Ho E.H., Cantor E.H., Lumma W.C., Parker-Botelho L.H. Cytoprotective functions of nitric oxide. inactivation of superoxide radicals produced by human leukocytes Biochem Biophys Res Commun. 181:1991;1392-1397.
35. Stabler S.P., Marcell P.D., Podell E.R., Allen R.H., Savage D.G., Lindenbaum J. Elevations of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chomatography-mass spectrometry. J Clin Invest. 81:1988;466-474.
36. Stamler J.S., Osborne J.A., Jaraki O., Rabbani L.E., Mullins M., Singel D., Loscalzo J. Adverse ascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 91:1993;308-318.
37. Stampfer M.J., Malinow M.R. Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med. 332:1995;328-329.
38. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxids generation from homocysteine. J Clin Invest. 77:1986;1370-1376.
39. Tsao P.S., Aoki N., Lefer D.J., Johnson G., Lefer A.M. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 82:1990;1402-1412.
40. Tsukahara J., Gordienko D.V., Goligorsky M.S. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem Biophys Res Commun. 193:1993;722-729.
41. Vedder N.B., Harlan J.M. Increased surface expression of CD11b/CD18 (MAC-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest. 81:1988;676-682.
42. von Andrian U.H., Chambers J.D., McEvoy L.M., Bargatze R.F., Arfors K.E., Butcher E.C. Two-step model of leukocyte-endothelial cell interaction in inflammation. distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo Proc Natl Acad Sci U S A. 88:1991;7538-7542.
43. Wall R.T., Harlan J.M., Harker L.A., Striker G.E. Homocysteine-induced endothelial cell injury in vitro. a model for the study of vascular injury Thromb Res. 18:1980;113-117.
44. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med. 320:1989;365-376.
45. Weyrich A.S., Ma X.L., Lefer D.J., Albertine K.H., Lefer A.M. In vitro neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest. 91:1993;2620-2629.
46. Weyrich A.S., Buerke M., Albertine K.H., Lefer A.M. Time course of coronary vascular endothelial adhesion molecules expression during reperfusion of the ischemic feline myocardium. J Leukocyte Biol. 57:1995;45-55.
47. Williams J.H.J., Moser K.M., Ulich T., Cairo M.S. Harvesting of the noncirculating pool of polymorphonuclear leukocytes in rats by hetastarch exchange transfusion (HET). yield and functional assessment J Leukocyte Biol. 42:1987;455-462.